Access cutting-edge premenstrual dysphoric disorder treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access premenstrual dysphoric disorder specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related premenstrual dysphoric disorder treatment provided free
Premenstrual dysphoric disorder (PMDD) is a severe affective disorder impacting millions of women worldwide, thought to be due to altered sensitivity to hormone fluctuations across the menstrual cycle. Neuroactive steroid hormones (NAS) and the gamma-aminobutyric acid (GABA)-A receptor (GABAAR) are thought to play a role in PMDD. This research will assess the blood levels of GABAergic NAS, expression of associated enzymes, and expression of GABAAR subunits across the premenstrual (luteal) phase
Sponsor: Johns Hopkins University
Check if you qualify for this premenstrual dysphoric disorder clinical trial in Baltimore, MD
If you're searching for premenstrual dysphoric disorder treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced premenstrual dysphoric disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.